Literature DB >> 8931959

Epidemiology of prostate cancer.

G A Dijkman1, F M Debruyne.   

Abstract

Prostate cancer is currently one of the most common malignancies worldwide. The incidence of prostate cancer has risen dramatically over the last decade, more so than can be explained by increasing longevity. Mortality rates have also risen, though not as dramatically. There is a wide geographic variation in the incidence of clinical prostate cancer, with higher rates in the United States than in China. One risk factor which could explain this variation is the high fat intake associated with a Western diet. It is also apparent that prostate cancer is now being detected at less advanced stages than in the past. Increased awareness of the disease and improved detection methods are thought to contribute to this earlier detection.

Entities:  

Mesh:

Year:  1996        PMID: 8931959     DOI: 10.1159/000474185

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  14 in total

1.  Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro.

Authors:  S H Lang; N W Clarke; N J George; N G Testa
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade.

Authors:  K Gyftopoulos; P Perimenis; G Sotiropoulou-Bonikou; G Sakellaropoulos; I Varakis; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

3.  Emergent trends in the reported incidence of prostate cancer in Nigeria.

Authors:  Godwin O Ifere; Fisseha Abebe; Godwin A Ananaba
Journal:  Clin Epidemiol       Date:  2012-01-10       Impact factor: 4.790

4.  Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis.

Authors:  I P Nnane; B J Long; Y Z Ling; D N Grigoryev; A M Brodie
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

5.  In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates.

Authors:  S H Lang; M Stower; N J Maitland
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.

Authors:  O Bratt; A Borg; U Kristoffersson; R Lundgren; Q X Zhang; H Olsson
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.

Authors:  Z Culig; J Hoffmann; M Erdel; I E Eder; A Hobisch; A Hittmair; G Bartsch; G Utermann; M R Schneider; K Parczyk; H Klocker
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

8.  Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages.

Authors:  Rui Medeiros; Bruno Horta; Joana Freitas-Silva; Jani Silva; Francisca Dias; Emília Sousa; Madalena Pinto; Fátima Cerqueira
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

9.  Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

Authors:  Marnix G E H Lam; Amel Dahmane; Wil H M Stevens; Peter P van Rijk; John M H de Klerk; Bernard A Zonnenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-22       Impact factor: 9.236

10.  Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer.

Authors:  Lindsay J. Stanbridge; Vincent Dussupt; Norman J. Maitland
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.